key: cord-0830705-u4hi0x6o
authors: Elgendy, Islam Y.; Kolte, Dhaval; Mansour, Michael K.; Sakhuja, Rahul; Elmariah, Sammy; Jaffer, Farouc A.; Neilan, Tomas G; Januzzi, James L.; Weinberg, Ido; Albaghdadi, Mazen S.
title: Incidence, Predictors, and Outcomes of Thrombotic Events in Hospitalized Patients With Viral Pneumonia
date: 2021-01-14
journal: Am J Cardiol
DOI: 10.1016/j.amjcard.2021.01.001
sha: f9943ec3a71499300eee006acbeda29ff702f469
doc_id: 830705
cord_uid: u4hi0x6o

nan

In this nationwide observational study of >455,000 hospitalizations for viral pneumonia, we found that thrombotic events were not uncommon (~3.0%). Several baseline characteristics and comorbidities were independently associated with thrombotic events. The development of thrombotic events among these patients was associated with increased in-hospital mortality, longer LOS, increased utilization of skilled nursing care following discharge, and higher costs.

Prior studies have focused on AMI and were limited to influenza infection only. 4 The current study extends our knowledge by examining the prevalence of any thrombotic event and included any etiology of viral pneumonia. These findings are relevant to the current COVID-19 pandemic caused by SARS-CoV-2, which has been linked to an increased risk of arterial and venous thrombotic events potentially related to direct viral infection or the profound inflammatory response. 3 This analysis is limited by the observational nature of the study and potential residual confounding. The unit of analysis is the number of hospitalizations rather than individual patients, and the NIS lacks data on therapies or investigations performed as well as outcomes beyond the index hospitalization. Despite these limitations, our study provides important insights into the incidence, risk factors, and outcomes of thrombotic events in hospitalized patients with infection on in-hospital acute myocardial infarction outcomes. Am J Cardiol 2020;130:7-14. 

Mortality associated with influenza and respiratory syncytial virus in the United States

Risk of myocardial infarction and stroke after acute infection or vaccination

COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up: JACC Stateof-the-Art Review

Influence of influenza

viral pneumonia and may serve as a comparator once similar data emerge for SARS-CoV-2 pneumonia.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.